• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Aspidospermatan-type alkaloids Aspidospermatan-type alkaloids
• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Aspidospermatan-type alkaloids

Introduction to 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester (CAS No. 7222-35-7)

20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester (CAS No. 7222-35-7) is a complex organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmacology. This compound is a derivative of aspidospermidine, a naturally occurring indole alkaloid found in various plants, particularly those belonging to the Apocynaceae family. The unique structural features and biological activities of this compound make it a valuable candidate for further research and potential therapeutic applications.

The chemical structure of 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester is characterized by its intricate indole core, substituted with a 3-methyl-but-2-enoyloxy group at the C-20 position and a carboxylic acid methyl ester at the C-3 position. This specific arrangement of functional groups imparts unique properties to the molecule, including its ability to interact with various biological targets.

Recent studies have highlighted the potential of 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester in several therapeutic areas. One of the most promising applications is in the treatment of neurological disorders. Research has shown that this compound exhibits potent neuroprotective effects, which may be attributed to its ability to modulate neurotransmitter systems and reduce oxidative stress. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound effectively protected neuronal cells from oxidative damage induced by hydrogen peroxide, suggesting its potential as a neuroprotective agent.

In addition to its neuroprotective properties, 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester has also been investigated for its anti-inflammatory and anti-cancer activities. In vitro studies have shown that this compound can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, making it a potential candidate for treating inflammatory diseases. Furthermore, preliminary research has indicated that this compound can induce apoptosis in cancer cells, particularly in breast and colon cancer cell lines. These findings suggest that 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester may have broad-spectrum therapeutic applications beyond neurological disorders.

The pharmacokinetic properties of 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester are another area of active research. Understanding how this compound is absorbed, distributed, metabolized, and excreted in the body is crucial for optimizing its therapeutic potential. Studies have shown that this compound has good oral bioavailability and a favorable half-life, which are important factors for drug development. However, further research is needed to fully elucidate its pharmacokinetic profile and identify any potential side effects or drug interactions.

The synthesis of 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester is a complex process that involves multiple steps and requires precise control over reaction conditions. The starting material is typically aspidospermidine or a related indole alkaloid, which undergoes a series of chemical transformations to introduce the desired functional groups. Recent advancements in synthetic chemistry have led to more efficient and scalable methods for producing this compound, making it more accessible for both research and potential commercial applications.

In conclusion, 20-(3-methyl-but-2-enoyloxy)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester (CAS No. 7222-35-7) is a promising compound with a wide range of potential therapeutic applications. Its unique chemical structure and biological activities make it an attractive target for further research in medicinal chemistry and pharmacology. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic potential, this compound may play a significant role in the development of novel treatments for various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)